αs1-CN f (143–149) (acetate)
αs1-CN f (143–149) acetate is an orally active casein-derived peptide sequence. αs1-CN f (143–149) acetate exhibits angiotensin-converting enzyme (ACE) inhibitory activity (IC50=6.58 μM) and antihypertensive activity[1].
Product Specifications
UNSPSC
12352209
Target
Angiotensin-converting Enzyme (ACE)
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Cardiovascular Disease
Purity
99.32
Smiles
OC(C=C1)=CC=C1C[C@H](NC([C@@H](NC([C@@H](NC([C@@H](N)C)=O)CC2=CC=C(C=C2)O)=O)CC3=CC=CC=C3)=O)C(N4[C@@H](CCC4)C(N[C@@H](CCC(O)=O)C(N[C@H](C(O)=O)CC(C)C)=O)=O)=O.CC(O)=O.[x]
Molecular Formula
C46H59N7O12.xC2H4O2
Molecular Weight
902.00 (free base)
References & Citations
[1]M del Mar Contreras, et al. "Novel casein-derived peptides with antihypertensive activity." International dairy journal 19.10 (2009) : 566-573.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
K0505405 3x 1.0 µg
CREB3L1 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
Sign In for Pricing
View Details 
